PTCT Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial; OMER Inhibits Thrombus Formation By: TalkMarkets November 20, 2014 at 06:37 AM EST PTCT announced today that its joint development program in Spinal Muscular Atrophy, Read More >> Related Stocks: Omeros Corp Ptc Therapeutics